Genetic interactions among targets of master regulator genes as drivers of complex behavior in Drosophila intestinal stem cells
Genetic interactions among targets of master regulator genes as drivers of complex behavior in Drosophila intestinal stem cells
批准号:
10629992
负责人:
Mariano A Loza Coll
金额:
$14.75万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2027-06-30
关键词:
AddressAffectAutomobile DrivingBehaviorBindingBiological AssayBiological ModelsBiomedical ResearchCell CountCell Differentiation processCell TherapyChemical InjuryCombined Modality TherapyComplementComplexCritical PathwaysDNADevelopmentDrosophila genusDrosophila melanogasterEnterocytesEnteroendocrine CellEpidermal Growth Factor ReceptorExperimental ModelsFamilyFosteringFuture GenerationsGastrointestinal DiseasesGene TargetingGeneticGenetic TranscriptionGoalsHormone secretionImageImmunofluorescence MicroscopyIndividualInfectionInjuryInterventionIntestinesInvestmentsKnowledgeLongevityMAPK8 geneMapsMidgutMinorityMissionMitoticMolecularMorphologyOrganOutcomePathogenicityPathway interactionsPhenotypeRegenerative MedicineRegenerative capacityRegulationRegulator GenesRegulatory PathwayReporterResearchResearch PersonnelResearch Project GrantsSTAT proteinScienceSignal PathwaySignal TransductionSignal Transduction PathwaySisterSnailsStainsStatistical Data InterpretationStudentsSystemTestingTherapeuticTissuesToxic effectUnderrepresented StudentsUnited States National Institutes of HealthUniversitiesadult stem cellautomated image analysisbody systemcell behaviorcell typecombinatorialdesigneducational atmospheregene conservationgenome-wideimprovedimproved outcomein vivoinnovationintestinal barrierintestinal homeostasismodel organismnotch proteinnovel strategiesprematurepreventpublic trustregeneration functionregeneration potentialself-renewalside effectstem cell functionstem cell proliferationstem cell therapystem cellstherapeutic candidatetherapeutic targettherapy developmenttissue stem cellstraining opportunitytranscription factorundergraduate student
中文摘要
项目总结
几个主调节(MR)基因已经在跨器官的组织干细胞中得到了表征
物种。然而,它们仍然是治疗操作的糟糕候选者,因为它们高度
多效性,影响数百个目标,并在许多器官系统中运作。因此,只有
更好地理解下游多效性较低的MR靶点如何协调干细胞增殖,
自我更新和分化将释放干细胞在再生医学中的全部潜力。这个
这个项目的长期目标是绘制出吉恩斯先生和他们的
以果蝇黑腹果蝇为模型系统的肠道干细胞(ISCs)靶点的研究。
果蝇的ISCs不对称分裂,产生了一个新的ISC和一个将成为
可吸收的肠细胞(EC)或分泌激素的肠内分泌细胞(EE)。具体的假设
推动这一提议的是MR靶通路之间的交叉调控相互作用可以导致非
当它们同时被操纵时,ISC行为的线性、不可预测的结果。为了测试这一点
假说,CAP,Klarid和Indy,ISC MR基因的三个实验验证靶点
和STAT,将在ISCS内使用可诱导的GAL4/UAS系统单独或组合操作。
他们单独和联合操作对肠道内环境平衡的影响将通过以下方式进行评估
三种独立但相辅相成的方法。在目标1中,将使用免疫荧光显微镜
比较ISC数量、形态、有丝分裂率和分化潜能
细胞类型标记物(ISCs的ESG-GFP,EBS的SU(H)激活,ECs和EES的Pdm1和Pros染色,
)。通过ImageJ和CellProfiler进行的自动图像分析将用于分析
每组图像,允许对数据进行可靠的统计分析。在Aim 2中,荧光活动记者
将用于比较单MR目标和双MR目标操作对关键ISC信号的影响
转导途径(EGFR、Notch、Wnt、STAT和JNK)。在目标3中,寿命和肠道屏障
完整性(SMurf)分析将用于比较单独和联合MR靶点的效果
手法对化学性损伤后肠组织再生能力的影响
病原体感染。这些研究目的可能会产生证据,挑战人们普遍持有的
前提是联合治疗只能通过相加补充才能改善结果
积极的影响。如果是这样的话,这个项目将对我们研究干细胞的概念方法产生重大影响。
再生医学的手法。此外,这个项目是专门设计的,目的是让
大量来自生物医学研究背景不足的学生,满足了另一个
NIH的重要使命:使科学劳动力多样化,从而促进创新,改进
提高科研质量,增强公众对科学的信任和投入。
英文摘要
PROJECT SUMMARY
Several master regulator (MR) genes have been characterized in tissue stem cells across organs and
species. However, they remain poor candidates for therapeutic manipulation because they are highly
pleiotropic, affecting hundreds of targets and operating across many organ systems. Therefore, only a
better understanding of how less pleiotropic downstream MR targets coordinate stem cell proliferation,
self-renewal and differentiation will unlock the full potential of stem cells in regenerative medicine. The
long-term goal of this project is to map the regulatory landscape established by MR genes and their
targets in intestinal stem cells (ISCs), using the fruit fly Drosophila melanogaster as a model system.
Drosophila ISCs divide asymmetrically, giving rise to a new ISC and a sister that will become an
absorptive enterocyte (EC) or a hormone-secreting enteroendocrine cell (EE). The specific hypothesis
driving this proposal is that cross-regulatory interactions between MR target pathways can lead to non-
linear, unpredictable outcomes on ISC behavior when they are manipulated simultaneously. To test this
hypothesis, CAP, Klaroid and Indy, three experimentally validated targets of the ISC MR genes Escargot
and STAT, will be manipulated alone or in combination within ISCs using an inducible Gal4/UAS system.
The effect of their individual vs. combined manipulations on intestinal homeostasis will be assessed via
three separate but complementary approaches. In Aim 1, immunofluorescence microscopy will be used
to compare ISC number, morphology, mitotic rate, and differentiation potential, based on well-established
cell type markers (esg-GFP for ISCs, Su(H) activation for EBs, Pdm1 and Pros staining for ECs and EEs,
respectively). Automated image analysis through ImageJ and CellProfiler will be used to analyze multiple
images per group, allowing a robust statistical analysis of the data. In Aim 2, fluorescent activity reporters
will be used to compare the effect of single vs. dual MR target manipulations on key ISC signal
transduction pathways (EGFR, Notch, Wnt, STAT and JNK). In Aim 3, lifespan and intestinal barrier
integrity (Smurf) assays will be used to compare the effect that individual vs. combined MR target
manipulations have on the regenerative capacity of intestinal tissue following chemical injury or
pathogenic infection. These research aims may generate evidence that challenges the widely held
premise that combination therapies can only improve outcome due to additive complementation of
positive effects. If so, this project will have a significant impact on our conceptual approach to stem cell
manipulation for regenerative medicine. In addition, this project was specifically designed to engage a
large number of students from underrepresented backgrounds in biomedical research, satisfying another
important mission of the NIH: to diversify the scientific workforce, and thus foster innovation, improve
research quality and enhance the public trust and investment in science.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic co-regulation by master transcription factors in Drosophila intestinal stem cells
-
批准号:9980960
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2018
-
负责人:Mariano A Loza Coll
-
依托单位:
海外基金